Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC)
Abroad (travel likely)RecruitingPHASE2
Conditions
Prostate Adenocarcinoma · Metastatic Prostate Adenocarcinoma · Castration-resistant
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Amber Michalik, Baltimore, Maryland, United States
Moinhos de Vento Hospital, Porto Alegre, Brazil
Contact: Study coordinator (Pedro Isaacsson Velho, M,D) · pedro.isaacsson@hmv.org.br · +55 51 980609999
Study leads
Pedro Isaacsson Velho, M,D
Principal Investigator
Moinhos de Vento Hospital
Samuel Denmeade, M,D
Principal Investigator
Sidney Kimmel Comprehensive Cancer Center at the Johns Hopkins Hospital